In these conditions, ETV4 would be an interesting marker for screening the CIC fusions in the spectrum of high‐grade glial/glioneuronal tumors, IDH, H3‐ and BRAF‐wildtype. Here, BRAF is linked to mixed neuronal-glial tumor.